Local Infiltration Analgesia + Dexamethasone For Pain Management After Total Joint Arthroplasty .
Dexamethasone as additive of local infiltration analgesia reduces opioids consumption after simultaneous bilateral total hip or knee arthroplasty: a randomized controlled double-blind trial.
J Orthop Surg Res . 2023 Sep 22;18(1):715.108 patients undergoing elective primary simultaneous bilateral total hip or knee arthroplasty were randomized to receive either local infiltration analgesia (LIA) with dexamethasone (DEX) (n=54) or active LIA plus saline (n=54). The primary outcome of interest was total morphine consumption at 24 hours. Secondary outcomes of interest included total morphine consumption at 48 and 72 hours, pain at rest and with activity on a Visual Analog Scale (VAS), Dezocine use, and the incidence of adverse events. Total morphine consumption, nausea on postoperative days (POD) 0 and 1, and vomiting on POD 0 were all significantly lower in the dexamethasone group. All other outcomes at all time points were similar between the two groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
